T1	Eq-Comparison 31 42	over age 18
E1	Eq-Comparison:T1 Value:T95
T2	And 43 47	with
E2	And:T2
T3	Procedure 55 61	biopsy
E3	Procedure:T3 Name:T96
T4	Condition 69 79	borderline
E4	Condition:T4
T5	Or 80 82	or
E5	Or:T5
T6	Risk 88 92	risk
E6	Risk:T6
T7	Condition 93 106	breast lesion
E7	Condition:T7 Name:T98
T8	Assertion 112 120	requires
E8	Assertion:T8
A1	Assertion-Type-Value E8 hypothetical
T9	Procedure 129 152	excision for management
E9	Procedure:T9 Name:T99
T10	And 258 261	who
E10	And:T10
T11	Risk 282 286	risk
E11	Risk:T11
T12	Eq-Comparison 298 314	greater than 25%
E12	Eq-Comparison:T12 Operator:T102 Value:T103 Unit:T104
T13	Risk 324 328	risk
E13	Risk:T13
T14	Modifier 332 338	breast
E14	Modifier:T14
T15	Condition 339 345	cancer
E15	Condition:T15 Name:T105
T16	Modifier 357 361	IBIS
E16	Modifier:T16
T17	Modifier 363 383	International Breast
E17	Modifier:T17
T18	Condition 384 390	Cancer
E18	Condition:T18
T19	Study 404 409	Study
E19	Study:T19
T20	Modifier 411 417	Breast
E20	Modifier:T20
T21	Condition 418 424	Cancer
E21	Condition:T21 Name:T106
T22	Procedure 451 460	Pathology
E22	Procedure:T22
T23	Assertion 469 476	felt to
E23	Assertion:T23
A2	Assertion-Type-Value E23 hypothetical
T24	Procedure 496 503	imaging
E24	Procedure:T24 Name:T109
T25	Eq-Comparison 509 518	Extensive
E25	Eq-Comparison:T25
T26	Condition 519 533	calcifications
E26	Condition:T26
T27	Eq-Comparison 544 559	more than 20 mm
E27	Eq-Comparison:T27 Operator:T111 Value:T112 Unit:T113
T28	Or 560 566	and/or
E28	Or:T28
T29	Observation 567 573	masses
E29	Observation:T29
T30	Eq-Comparison 574 592	greater than 30 mm
E30	Eq-Comparison:T30 Operator:T114 Value:T115 Unit:T116
T31	Condition 612 619	lesions
E31	Condition:T31 Name:T117
T32	Negation 628 636	excluded
E32	Negation:T32
T33	Risk 662 666	risk
E33	Risk:T33
T34	Condition 670 679	upstaging
E34	Condition:T34
T35	Condition 681 688	lesions
E35	Condition:T35 Name:T119
T36	Exception 690 700	other than
E36	Exception:T36
T37	Condition 701 714	fibroadenomas
E37	Condition:T37 Name:T120
T38	Condition 716 725	phyllodes
E38	Condition:T38
T39	Or 726 729	and
E39	Or:T39
T40	Condition 730 740	papillomas
E40	Condition:T40 Name:T121
T41	Condition 769 782	palpable mass
E41	Condition:T41 Name:T122
T42	Condition 784 787	ADH
E42	Condition:T42 Name:T123
T43	Condition 798 816	ductal hyperplasia
E43	Condition:T43 Name:T124
T44	And 818 822	with
E44	And:T44
T45	Modifier 823 832	high-risk
E45	Modifier:T45
T46	Condition 833 841	features
E46	Condition:T46
T47	Condition 843 846	ADH
E47	Condition:T47 Name:T126
T48	And 847 851	with
E48	And:T48
T49	Condition 852 866	zonal necrosis
E49	Condition:T49 Name:T127
T50	Condition 880 898	cytological atypia
E50	Condition:T50 Name:T129
T51	Or 899 901	or
E51	Or:T51
T52	Eq-Comparison 902 918	more than 2 foci
E52	Eq-Comparison:T52 Operator:T130 Value:T131 Unit:T132
T53	Procedure 921 925	LCIS
E53	Procedure:T53
T54	Modifier 927 934	lobular
E54	Modifier:T54
T55	Condition 935 944	carcinoma
E55	Condition:T55 Name:T134
T56	Procedure 948 952	situ
E56	Procedure:T56
T57	And 954 958	with
E57	And:T57
T58	Modifier 959 968	high-risk
E58	Modifier:T58
T59	Condition 969 977	features
E59	Condition:T59
T60	Condition 995 998	ADH
E60	Condition:T60 Name:T136
T61	Condition 1000 1016	pleomorphic LCIS
E61	Condition:T61 Name:T137
T62	Condition 1018 1032	zonal necrosis
E62	Condition:T62 Name:T138
T63	And 1033 1036	and
E63	And:T63
T64	Eq-Comparison 1037 1040	> 4
E64	Eq-Comparison:T64 Operator:T139 Value:T140
T65	Modifier 1041 1045	foci
E65	Modifier:T65
T66	Or 1047 1049	or
E66	Or:T66
T67	Modifier 1050 1060	discordant
E67	Modifier:T67
T68	Procedure 1066 1073	imaging
E68	Procedure:T68 Name:T142
T69	Condition 1075 1084	papilloma
E69	Condition:T69
T70	Modifier 1090 1096	atypia
E70	Modifier:T70
T71	Or 1098 1101	and
E71	Or:T71
T72	Modifier 1102 1114	spindle cell
E72	Modifier:T72
T73	Condition 1115 1121	lesion
E73	Condition:T73
T74	Condition 1160 1167	Lesions
E74	Condition:T74 Name:T144
T75	Assertion 1177 1187	suspicious
E75	Assertion:T75
A3	Assertion-Type-Value E75 possible
T76	Condition 1192 1202	borderline
E76	Condition:T76
T77	Or 1203 1205	or
E77	Or:T77
T78	Modifier 1206 1215	malignant
E78	Modifier:T78
T79	Condition 1216 1225	Phyllodes
E79	Condition:T79 Name:T145
T80	Condition 1227 1231	DCIS
E80	Condition:T80 Name:T146
T81	Condition 1233 1249	ductal carcinoma
E81	Condition:T81 Name:T147
T82	Modifier 1253 1257	situ
E82	Modifier:T82
T83	Modifier 1260 1276	invasive mammary
E83	Modifier:T83
T84	Condition 1277 1286	carcinoma
E84	Condition:T84
T85	Or 1288 1290	or
E85	Or:T85
T86	Modifier 1291 1313	encapsulated papillary
E86	Modifier:T86
T87	Condition 1314 1323	carcinoma
E87	Condition:T87
T88	Condition 1333 1339	lesion
E88	Condition:T88 Name:T150
T89	Negation 1401 1404	not
E89	Negation:T89
T90	Assertion 1405 1413	amenable
E90	Assertion:T90
A4	Assertion-Type-Value E90 hypothetical
T91	Modifier 1417 1421	VAPE
E91	Modifier:T91
T92	Or 1422 1424	or
E92	Or:T92
T93	Procedure 1425 1442	surgical excision
E93	Procedure:T93 Name:T151
T94	Life-Stage-And-Gender 25 30	Women
A5	Life-Stage-And-Gender-Type T94 female
T95	Eq-Value 40 42	18
T96	Procedure-Name 55 61	biopsy
T97	Polarity 83 87	high
A6	Polarity-Value T97 high
T98	Condition-Name 93 106	breast lesion
T99	Procedure-Name 129 152	excision for management
T100	Life-Stage-And-Gender 252 257	Women
A7	Life-Stage-And-Gender-Type T100 female
T101	Polarity 277 281	high
A8	Polarity-Value T101 high
T102	Eq-Operator 298 310	greater than
A9	Eq-Operator-Value T102 GT
T103	Eq-Value 311 313	25
T104	Eq-Unit 313 314	%
T105	Condition-Name 339 345	cancer
T106	Condition-Name 418 424	Cancer
T107	Procedure-Name 430 445	Evaluation Tool
T108	Condition-Name 451 460	Pathology
T109	Procedure-Name 496 503	imaging
T110	Condition-Name 509 533	Extensive calcifications
T111	Eq-Operator 544 553	more than
A10	Eq-Operator-Value T111 GT
T112	Eq-Value 554 556	20
T113	Eq-Unit 557 559	mm
T114	Eq-Operator 574 586	greater than
A11	Eq-Operator-Value T114 GT
T115	Eq-Value 587 589	30
T116	Eq-Unit 590 592	mm
T117	Condition-Name 612 619	lesions
T118	Polarity 652 661	increased
A12	Polarity-Value T118 high
T119	Condition-Name 681 688	lesions
T120	Condition-Name 701 714	fibroadenomas
T121	Condition-Name 730 740	papillomas
T122	Condition-Name 769 782	palpable mass
T123	Condition-Name 784 787	ADH
T124	Condition-Name 798 816	ductal hyperplasia
T125	Polarity 823 827	high
A13	Polarity-Value T125 high
T126	Condition-Name 843 846	ADH
T127	Condition-Name 852 866	zonal necrosis
T128	Severity 868 879	significant
A14	Severity-Value T128 severe
T129	Condition-Name 880 898	cytological atypia
T130	Eq-Operator 902 911	more than
A15	Eq-Operator-Value T130 GT
T131	Eq-Value 912 913	2
T132	Eq-Unit 914 918	foci
T133	Condition-Name 921 925	LCIS
T134	Condition-Name 935 944	carcinoma
T135	Polarity 959 963	high
A16	Polarity-Value T135 high
T136	Condition-Name 995 998	ADH
T137	Condition-Name 1000 1016	pleomorphic LCIS
T138	Condition-Name 1018 1032	zonal necrosis
T139	Eq-Operator 1037 1038	>
A17	Eq-Operator-Value T139 GT
T140	Eq-Value 1039 1040	4
T141	Eq-Unit 1041 1045	foci
T142	Procedure-Name 1066 1073	imaging
T143	Condition-Name 1102 1121	spindle cell lesion
T144	Condition-Name 1160 1167	Lesions
T145	Condition-Name 1216 1225	Phyllodes
T146	Condition-Name 1227 1231	DCIS
T147	Condition-Name 1233 1249	ductal carcinoma
T148	Condition-Name 1269 1286	mammary carcinoma
T149	Condition-Name 1304 1323	papillary carcinoma
T150	Condition-Name 1333 1339	lesion
T151	Procedure-Name 1425 1442	surgical excision